Euro-Med Laboratories Philippines (PHS:EURO) EPS (Basic): ₱0.11 (TTM As of Mar. 2026)


PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
84 GF Score
Price ₱1.08
GF Value ₱1.02
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines EPS (Basic)?

Euro-Med Laboratories Philippines PHS:EURO 84 EPS (Basic) is ₱0.11 as of Mar. 2026. GuruFocus rates PHS:EURO with a GF Score™ of 84/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 6 warning signs investors should review.

Euro-Med Laboratories Philippines's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₱0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₱0.11.

Euro-Med Laboratories Philippines's EPS (Diluted) for the three months ended in Mar. 2026 was ₱0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₱0.11.

Euro-Med Laboratories Philippines's EPS without NRI for the three months ended in Mar. 2026 was ₱0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.11.

During the past 12 months, Euro-Med Laboratories Philippines's average EPS without NRIGrowth Rate was 41.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 26.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Euro-Med Laboratories Philippines's highest 3-Year average EPS without NRI Growth Rate was 30.60% per year. The lowest was -28.80% per year. And the median was 3.85% per year.

Euro-Med Laboratories Philippines  (PHS:EURO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Euro-Med Laboratories Philippines EPS (Basic) Related Terms

Euro-Med Laboratories Philippines EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines EPS (Basic) Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.05 0.07 0.08 0.11

Euro-Med Laboratories Philippines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.03 0.04 0.02
PHS:EURO
84GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euro-Med Laboratories Philippines EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Euro-Med Laboratories Philippines's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(470.296-0)/4112.141
=0.11

Euro-Med Laboratories Philippines's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(82.612-0)/4112.141
=0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₱0.11 mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a EPS (Basic) of ₱0.11 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Euro-Med Laboratories Philippines and its competitors.
Is Euro-Med Laboratories Philippines' EPS (Basic) too high?
Euro-Med Laboratories Philippines' current EPS (Basic) is ₱0.11. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' EPS (Basic) compare to ZTS and UTHR?
Euro-Med Laboratories Philippines' EPS (Basic) of ₱0.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Euro-Med Laboratories Philippines and its competitors. Euro-Med Laboratories Philippines's current EPS (Basic) is ₱0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.08 — trading 5.9% above its estimated fair value. The current EPS (Basic) is ₱0.11. Euro-Med Laboratories Philippines' overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current EPS (Basic) is ₱0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.08 is trading 5.9% above its estimated GF Value™ of ₱1.02. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • EPS (Basic): ₱0.11
  • GF Value™: ₱1.02 vs. price of ₱1.08 (5.9% above fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
84GF Score

Get the complete analysis for PHS:EURO

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.08
Price
₱1.02
GF Value